Case Study: Leading Global Pharmaceutical Company achieves 35% reduction in recruitment timeline with IQVIA Biotech

Recruitment Management Plan Reduces Timeline by 35%

Leading Global Pharmaceutical Company engaged IQVIA to support a large Phase II onychomycosis study requiring 440–460 patients across 25 U.S. and Canadian sites. The sponsor anticipated enrollment would take about 52 weeks and faced the risk of site under-enrollment delaying the program, so IQVIA Biotech was asked to deploy its Recruitment Management Plan (RMP) and patient recruitment process to accelerate enrollment.

IQVIA used a targeted U.S.–Canada marketing campaign (radio and daytime TV) plus real‑time enrollment analytics to dynamically adjust site-level outreach. IQVIA Biotech recruited 443 randomized subjects in 33 weeks (a 35% reduction versus the sponsor’s original 52‑week estimate), contributed 83% of all enrollees (sites 17%), met demographic targets (78% male; 83% aged 40–60), exceeded response and cost‑per‑response expectations, and accomplished this using less than two‑thirds of the planned advertising budget.